Literature DB >> 21457429

Single-incision sling system as primary treatment of female stress urinary incontinence: prospective 12 months data from a single institution.

Rui Oliveira1, Francisco Botelho, Pedro Silva, Alexandre Resende, Carlos Silva, Paulo Dinis, Francisco Cruz.   

Abstract

OBJECTIVE: To investigate the success and complication rates for Mini-Arc(TM) single incision sling in the treatment of female stress urinary incontinence (SUI).
MATERIALS AND METHODS: A total of 119 female patients with pure SUI were enrolled in a prospective study. From these, 105 were available with a minimum follow-up of 6 months and a mean follow-up of 12 months. Success, as determined by patient- reported outcomes, and complication rates, as well as impact of learning curve, body mass index (BMI), intrinsic sphincter deficiency (ISD), incontinence severity and age were investigated.
RESULTS: Cure rate was 80% and improvement rate was 11%. Pain intensity was minimal on a visual analogue scale and transient urinary retention occurred in three patients, one requiring sling section. De novo urgency was reported by 6% of women. Severe incontinence was less likely to be cured: 70% if >5 pads per day (ppd); 94% if <2 ppd; 94% if 2-4 ppd, P < 0.05). There was no difference in success rates between the first 50 and the last 50 patients. BMI, ISD and age also did not influence success rate.
CONCLUSION: Mini-Arc™ attained high success rates at 1 year follow-up. The procedure was easy to learn and was associated with very low and mild morbidity. Severe incontinence was identified as a risk factor for failure.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 21457429     DOI: 10.1111/j.1464-410X.2011.10158.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  10 in total

Review 1.  Iatrogenic obstruction after sling surgery.

Authors:  Bhavin N Patel; Kathleen C Kobashi; David Staskin
Journal:  Nat Rev Urol       Date:  2012-06-05       Impact factor: 14.432

Review 2.  Treatment options for intrinsic sphincter deficiency.

Authors:  Sovrin M Shah; Geoffrey S Gaunay
Journal:  Nat Rev Urol       Date:  2012-10-02       Impact factor: 14.432

3.  Re: Not all minislings are alike.

Authors:  Maya Basu; Jonathan Duckett
Journal:  Int Urogynecol J       Date:  2014-09       Impact factor: 2.894

4.  Reply to letter to the editor re: Does body mass index influence the outcome of midurethral sling procedures for stress urinary incontinence?

Authors:  Jialei Qian; Deyi Luo
Journal:  Int Urogynecol J       Date:  2017-11-04       Impact factor: 2.894

5.  Mini-slings can cause complications.

Authors:  Burhan Coskun; Rebecca S Lavelle; Feras Alhalabi; Gary E Lemack; Philippe E Zimmern
Journal:  Int Urogynecol J       Date:  2014-10-23       Impact factor: 2.894

6.  Short-term outcomes of Altis single-incision sling procedure for stress urinary incontinence: a prospective single-center study.

Authors:  Jorge Dias; Luís Xambre; Luís Costa; Pedro Costa; Luís Ferraz
Journal:  Int Urogynecol J       Date:  2014-03-06       Impact factor: 2.894

7.  Single-Incision Slings (SIS) - a New Option for the Surgical Treatment of Female Stress Urinary Incontinence.

Authors:  G Naumann; S Albrich; C Skala; R Laterza; H Kölbl
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-02       Impact factor: 2.915

8.  Efficacy of TVT-SECUR and factors affecting cure of female stress urinary incontinence: 3-year follow-up.

Authors:  Ji-Yeon Han; Junsoo Park; Myung-Soo Choo
Journal:  Int Urogynecol J       Date:  2012-05-15       Impact factor: 2.894

9.  Mesh complications in female pelvic floor reconstructive surgery and their management: A systematic review.

Authors:  Hemendra N Shah; Gopal H Badlani
Journal:  Indian J Urol       Date:  2012-04

10.  Mini-arc for the treatment of female stress urinary incontinence: long-term prospective evaluation by patient reported outcomes.

Authors:  Rui Oliveira; Alexandre Resende; Carlos Silva; Paulo Dinis; Francisco Cruz
Journal:  ISRN Urol       Date:  2014-01-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.